Background: Polyposis disorders of the bowel in the pediatric population are associated with elevated risks of various cancers. The most common sites of the malignancies were the gastrointestinal system, breast, gynecological organs, testis, pancreas and lung. Testicular lesions are often overlooked as PJS predominantly appear in females.
Case: A 9-year-old boy was presented to gastroenterology policlinic due to pallor. He had a history of diagnostic laparotomy when he was nine dues to acute abdomen where intussusception related to ileal hamartomatous polyp was diagnosed. He had bluish-black pigmentations on the lips and oral mucosa and bilateral gynecomastia. His testicular examination showed no masses. Thelarche and pubarche was tanner stage 2. Laboratory findings did not reveal any pathological result, except anemia (Serum hemoglobin level: 8.1 gr/dl), low serum estradiol (< 5 pg/mL; reference range: 25.8-60.7) and follicle-stimulating hormone (FSH) (0.58 mIU/mL; reference range: 1.5-12.4) levels. Multiple and different sized polyps were discovered on colonoscopy and esophago-gastroduodenoscopy. Histopathological investigation of the polyps was compatible with hamartoma. The mutation analysis of the testicular specimen later identified a heterozygote mutation of patient's STK11 genes (p.Gly 163Arg), on exon 4, consistent with the clinical diagnosis of PJS. The skeletal age (11 years) was older than the chronological age. Mammary ultrasounds proved bilateral gynecomasty and testicular ultrasonography showed bilateral multiple microcalcifications. The histopathological examination of testes wedge biopsies showed multifocal intratubular large cell hyalinizing tumors of Sertoli cells. The patient was referred to pediatric endocrinology department where aromatase inhibition therapy was initiated. After follow-up of one year, gynecomasty on the right disappeared while it was just minimal on the left breast.
Conclusions: First, any child who was diagnosed to have invagination should have been checked for familial polyposis syndromes. Second, any child with the suspicion of PJS should have routine mammary and testes ultrasounds. Any abnormality especially in testicles needs further evaluation including biopsy. Unexpected malignant pathologic appearance can be seen even in the youngers. Last, malignant Sertoli cell tumors of the testes can be followed up prescribing aromatase inhibitors without any need for orchiectomy.
Introduction
Polyposis disorders of the bowel in the pediatric population require close medical care to minimize cancer risk in the gastrointestinal tract and in other organ systems [1] . Peutz-Jeghers syndrome (PJS), is a rare autosomal dominant disease manifests as multiple gastrointestinal hamartomatous polyposis, mucocutaneous pigmentation, and increased risk of gastrointestinal (GI) or extraintestinal neoplasia due to a germline mutation in the STK11(LKT1)/LKB1 gene located on the short arm of chromosome 19 [2] . The estimated lifetime cumulative cancer risk in individuals with PJS is over 76% in
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Check for updates are summarized in Table 1 . Multiple and different sized polyps were discovered on colonoscopy and esophago-gastroduodenoscopy (Table 2) . Polypectomy was performed, and histopathology was compatible with a hamartomatous polyp (Figure 1 ). The mutation analysis of the testicular specimen later identified a heterozygote mutation of patient's STK11 genes (p.Gly 163Arg), on exon 4, consistent with the clinical diagnosis of PJS.
The skeletal age (11 years) was older than the chronological age. Mammary ultrasounds proved bilateral gynecomasty and testicular ultrasonography showed bilateral multiple microcalcifications. The histopathological examination of testes wedge biopsies showed multifocal intratubular large cell hyalinizing tumors of Sertoli cells (Figure 2 ). The patient was referred to pediatric endocrinology department where aromatase inhibition therapy was initiated. After follow-up of one year, gynecomasty on the right disappeared while it was just minimal on the left breast.
Discussion
There is an age dependent symptom and complication range for patients with PJS: polyp-related complications may occur in childhood, whereas the gastrointestinal or genital cancer risks are predominantly associated with the adults [8] . Our case report is one of the few exceptions to this belief as he showed both polyps related and cancer related complications. Small intestine comparison with the common population [2] [3] [4] . In other words, an 11-fold elevated risk of cancer has been reported in PJS [5] . The most common sites of the malignancies were the gastrointestinal system, especially colorectum, small intestine including the duodenum, and stomach; followed by the breast, gynecological organs (uterus, cervix and ovary), testis, pancreas, and lung [5, 6] . Testicular lesions are often overlooked as PJS predominantly appear in females. Large cell calcifying sertoli cell tumors (LCCSCTs) have been associated with PJS. Most LCCSCTs have a benign clinical course, but malignancy rarely can occur especially in older ages. Malignancy is detected in about 17% of patients with LCCSCTs, usually occur at a mean age of 39 years while the mean age of presentation for benign tumors was 17 years [7] .
Sometimes, unrecognized clues may aid to put further diagnosis in rare syndromes. Here, we report a boy who was proved to have Peutz-Jeghers syndrome (PJS) and multifocal intratubular large cell hyalinizing Sertoli cells neoplasia. This is one of the few cases that malignant course had been diagnosed in a relatively younger age.
Case
Informed consent forms were filled by the parents before enrollment. A 9-year-old white Turkish citizen boy was presented to gastroenterology policlinic in Istanbul due to pallor. He had a history of diagnostic laparotomy when he was nine due to acute abdomen where intussusception related to ileal hamartomatous polyp was diagnosed. His parents were distant kinships and his paternal grandfather had a history of bowel operation with an unknown cause. Physical examination revealed a height of 122 cm (3-10.p) and weight of 22 kg (3-10.p). He had bluish-black pigmentations on the lips and oral mucosa. He had bilateral gynecomastia. His testicular examination showed no masses. Thelarche and pubarche was tanner stage 2. Laboratory findings it is in our patient [3, 12] . Invasive cancer risk is diminished in Sertoli cell tumors in young patients, in the existence of bilateral testicular involvement, and when they co-exist with genetic syndromes.
Sertoli cells are the structural cells of the testicles [7] . During the germinal maturation, Sertoli cells produce anti-Müllerian hormone (AMH) causing to degeneration of Müllerian ducts. Simultaneous testosterone stimulation of Leydig cells in fetus generates internal male genital organs [7] . Meantime the main duty of Sertoli cells is to induce the differentiation of spermatocytes [7] . Aromatase is the enzyme that converts testosterone to estradiol. This enzyme usually is not detected in testes before puberty and the level increases gradually thereafter. In normal situations, aromatase enzyme is produced mainly in Leydig cells; however, in testicular neoplasms that arise from Sertoli cells, these cells express aromatase [7, 13] .
Ulbright, et al. [11] proved elevated levels of aromatase in Sertoli Cell Tumors with positive immunostains, which may confirm the estrogenic hyperactivity in PJS. High aromatase levels cause increased serum levels of estradiol and estrone using testosterone and androstenedione as substrates. Thus, prepubertal gyneis the most typical localization of PJS polyps; also, colon and stomach are generally involved [9] . The cardinal clinical hallmarks of PJS are anemia, rectal bleeding, obstruction, and/or intussusception [9] . Our patient also referred to our policlinic as a result of anemia associated symptoms such as pallor, weakness and fatigue. His history later revealed an operation possibly due to obstruction and/or intussusception related to polyposis.
The first case of feminizing Sertoli cell tumor in a child with PJS has been described in 1980 by Cantu, et al. [10] . Ulbright, et al. declared that the testicular tumors seen in PJS patients largely appears as multifocal intratubular large cell hyalinizing tumors of Sertoli cells with a noticeable morphology that varies from LCCSCTs and sex cord tumors with annular tubules. However, most authors nowadays except that syndrome associated testis tumors are LCCSCTs [3, 11] . LCCSCTs occur with a frequency of 0.4-1.5% among testicular neoplasias [3] . They are sporadic in 60% of the published cases, but in the remaining cases they are associated with multiple neoplasia syndromes such as PJS and Carney complex [7] . Mainly, the neoplasm resides within the borders of the tubules for several years [3] . Quite seldom it has been declared to progress to invasive large cell sertoli cell tumors with or without co-existing calcification as comastia becomes a typical initial presentation as it is in our patient. Hyperestrogenism cannot be caught in biochemical analyses, as the hormone production is restricted to testicular aromatase.
The physiopathologic basis of LCCSCTs in patients suffering PJS is not established yet. Possible blamed mechanisms include inhibition of AMP-activated protein kinase that triggers activation of mammalian target of rapamycin (mTOR) [7] . Others suggest that the gene abnormality of PJS may induce a cascade of effects causing overexpression of aromatase, estrogen receptor and transforming growth factor-beta1 in Sertoli cells [14, 15] .
Seeing microcalcifications in testicular ultrasound is not pathognomonic for LCCSCTs, but 'Christmas tree-like' calcifications of multiple lesions in syndromic LCCSCTs is almost unique for the diagnosis of this neoplasm [16] . We were able to demonstrate testicular calcifications in our patient, but we could not see Christmas tree appearance.
The aims of therapy are to decrease the polyp burden and the likelihood of polyp related complications, especially intussusception/obstruction/bleeding, in the PJS patient; and, identification of neoplasm(s) at an early stage. Endoscopic polypectomy is advised at GI endoscopy and/or colonoscopy to decrease neoplasm risks [8] .
Although older reports courage orchiectomies in Sertoli cell tumors, the present management strategy is conservative including careful follow-up and ultrasound examination as these approaches avoid the long-term side effects of hypergonadotropic hypogonadism [17] . Aromatase inhibitors are the recommended pharmacotherapy for LCCSCTs [3, 7] . We also obtained acceptable results with this approach.
Conclusion

Any child who was diagnosed to have invagination
should have been checked for familial polyposis syndromes.
2. Any child with the suspicion of PJS should have routine mammary and testes ultrasounds. Any abnormality especially in testicles needs further evaluation including biopsy. Unexpected malignant pathologic appearance can be seen even in the youngers.
3. Malignant Sertoli cell tumors of the testes can be followed up prescribing aromatase inhibitors without any need for orchiectomy.
